Analysis of the Factors Influencing the Development of Hand-foot Syndrome in Patients Receiving Pegylated Liposomal Doxorubicin Therapy for Ovarian Cancer | Zendy

AI Assistant Blog Pricing

Analysis of the Factors Influencing the Development of Hand-foot Syndrome in Patients Receiving Pegylated Liposomal Doxorubicin Therapy for Ovarian Cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.